# OnCo record paper-nct02938299-ann-oncol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct02938299-ann-oncol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct02938299-ann-oncol-2025" ;
  schema:name "Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma"@en ;
  schema:description "Published report from the Neoadjuvant L19IL2 trial registered as NCT02938299, in Annals of Oncology (2025), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct02938299-ann-oncol-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.annonc.2025.06.014>, <https://pubmed.ncbi.nlm.nih.gov/40633690/>, <https://europepmc.org/article/MED/40633690>, <https://clinicaltrials.gov/study/NCT02938299> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.annonc.2025.06.014> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Kähler KC, Hassel JC, Ziemer M, et al." ;
  onco:trials <https://onco.cc/trials/nct02938299/> ;
  onco:journals <https://onco.cc/journals/annals-of-oncology/> .